Related Experiment Video
Updated: Mar 6, 2026
09:53
Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
898
[Myocardial Infarction and Natural Defense Mechanisms: The Role of Norepinephrine Reuptake]
S E Naumenko1, T V Latysheva1, M A Gilinsky1
1Scientific Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia.
Kardiologiia
|March 16, 2017
Summary
Norepinephrine reuptake blockade during reperfusion may reduce infarct size. This effect was studied with and without ischemic conditioning in a rat model, suggesting potential therapeutic strategies for myocardial infarction.
Area of Science:
- Cardiovascular research
- Ischemic heart disease
- Pharmacology
Background:
- Myocardial infarction (MI) remains a leading cause of mortality.
- Reperfusion therapy is crucial but can induce further injury.
- Modulating the sympathetic nervous system during reperfusion is a potential therapeutic target.
Purpose of the Study:
- To investigate the impact of norepinephrine reuptake blockade during reperfusion on infarct size.
- To evaluate this effect in the context of ischemic preconditioning and postconditioning.
- To assess the efficacy of desipramine in mitigating ischemia-reperfusion injury.
Main Methods:
- Wistar rats underwent 30 minutes of left coronary artery occlusion followed by 120 minutes of reperfusion.
- Groups received either no treatment, desipramine (a norepinephrine reuptake inhibitor) during reperfusion, or ischemic preconditioning.
- Further groups were planned to assess ischemic postconditioning and combined interventions.
Main Results:
- Preliminary data suggests desipramine administration during reperfusion may influence infarct size.
- Ischemic preconditioning demonstrated a protective effect against infarct expansion.
- Further analysis is required to elucidate the combined effects of pharmacological intervention and conditioning.
Conclusions:
- Norepinephrine reuptake inhibition during reperfusion warrants further investigation as a strategy to limit infarct size.
- Combining pharmacological approaches with established conditioning techniques may offer enhanced cardioprotection.
- This study provides a foundation for exploring novel therapeutic interventions for acute myocardial infarction.
Related Concept Videos
01:16Antianginal Drugs: Nitrates and β-Blockers
1.8K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
01:28Acute Coronary Syndrome IV: Interprofessional Care
358
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
358
01:14Myocarditis III: Medical Management
276
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
276
01:25Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K